hVIVO plc Chief Executive Officer Steps Down (3970L)
April 19 2018 - 2:01AM
UK Regulatory
TIDMHVO
RNS Number : 3970L
hVIVO plc
19 April 2018
For immediate release 7.00am: 19 April 2018
HVIVO PLC
("hVIVO" or the "Company")
Chief Executive Officer Steps Down
hVIVO plc (AIM: HVO), a pioneer of human disease models and an
industry leading clinical development and drug discovery services
business, announces that Kym Denny is stepping down as Chief
Executive of the Company with immediate effect.
Trevor Phillips, Executive Chairman, will take over Kym's
responsibilities.
Trevor Phillips, Executive Chairman of hVIVO plc said: "We would
like to thank Kym for her contribution to the Group and wish her
well for the future."
For further information please contact:
hVIVO plc
Trevor Phillips (Executive Chairman) +44 207 756 1300
Fleur Wood (Director, Investor Relations)
Numis Securities Limited +44 207 260 1000
Michael Meade / Freddie Barnfield
(Nominated Adviser)
James Black / Michael Burke (Corporate
Broking)
FTI Consulting
Simon Conway / Victoria Foster Mitchell +44 203 727 1000
This announcement is released by hVIVO plc and contains inside
information for the purposes of the Market Abuse Regulation (EU)
596/2014 ("MAR") and is disclosed in accordance with the Company's
obligations under Article 17 of MAR. The person who arranged for
the release of this announcement on behalf of hVIVO plc was Trevor
Phillips, Executive Chairman.
Notes to Editors:
hVIVO plc ("hVIVO") is pioneering a human-based analytical
platform to accelerate drug discovery and development in
respiratory and infectious diseases. Leveraging human disease
models in flu, RSV and asthma exacerbation, the hVIVO platform
captures disease in motion, illuminating the entire disease life
cycle from healthy to sick and back to health. Based in the UK,
market leader hVIVO has conducted more than 50 clinical studies,
inoculated over 2500 volunteers and has three first-in-class
therapies currently in development with a growing pre-clinical
pipeline.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOASFIEEAFASEEL
(END) Dow Jones Newswires
April 19, 2018 02:01 ET (06:01 GMT)
Hvivo (LSE:HVO)
Historical Stock Chart
From Apr 2024 to May 2024
Hvivo (LSE:HVO)
Historical Stock Chart
From May 2023 to May 2024